ICP: A novel approach to predict prognosis of prostate cancer with inner-class clustering of gene expression data
- 1 October 2013
- journal article
- research article
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 43 (10) , 1363-1373
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
- Ministry of Education, Science and Technology (20120002887, 2012010775)
This publication has 46 references indexed in Scilit:
- Genome wide gene expression regulation by HIP1 Protein Interactor, HIPPI: Prediction and validationBMC Genomics, 2011
- Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modulesBMC Cancer, 2010
- TMPRSS2–ERG gene fusion is associated with low Gleason scores and not with high-grade morphological featuresLaboratory Investigation, 2010
- Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancerCarcinogenesis, 2010
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Prostate cancer genes associated with TMPRSS2–ERG gene fusion and prognostic of biochemical recurrence in multiple cohortsBritish Journal of Cancer, 2010
- Differential expression of apoptotic genes PDIA3 and MAP3K5 distinguishes between low- and high-risk prostate cancerMolecular Cancer, 2009
- New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapyCancer Immunology, Immunotherapy, 2009
- Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic processBMC Cancer, 2007
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001